Cabelas, Inc. (CAB) Tops Q2 EPS by 1c; Comps up 10.5%
Get Alerts CAB Hot Sheet
Price: $61.50 --0%
Financial Fact:
Selling, distribution, and administrative expenses: 356.34M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Selling, distribution, and administrative expenses: 356.34M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cabelas, Inc. (NYSE: CAB) reported Q2 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $756.8 million versus the consensus estimate of $739.58 million. Second Quarter Comparable Store Sales Up 10.5%.
"This strong showing reflects excellent performance by our next-generation stores and our omni-channel marketing efforts," said Tommy Millner, Cabela's Chief Executive Officer. "Retail expansion continues as a highlight. Our next-generation stores provide the combination of exceptional customer experience and great use of retail space. These next-generation stores continue to yield sales and profit per square foot an extraordinary 40-plus percent better than our legacy stores. Additionally, our legacy stores continue to show improvement in revenue and profit per square foot themselves. We are excited as we continue to accelerate retail square footage expansion."
For earnings history and earnings-related data on Cabelas, Inc. (CAB) click here.
"This strong showing reflects excellent performance by our next-generation stores and our omni-channel marketing efforts," said Tommy Millner, Cabela's Chief Executive Officer. "Retail expansion continues as a highlight. Our next-generation stores provide the combination of exceptional customer experience and great use of retail space. These next-generation stores continue to yield sales and profit per square foot an extraordinary 40-plus percent better than our legacy stores. Additionally, our legacy stores continue to show improvement in revenue and profit per square foot themselves. We are excited as we continue to accelerate retail square footage expansion."
For earnings history and earnings-related data on Cabelas, Inc. (CAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
- BK Technologies (BKTI) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, Management Comments, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share